Cell‐specific actions of HIV‐Tat and morphine on opioid receptor expression in glia
- 13 March 2008
- journal article
- research article
- Published by Wiley in Journal of Neuroscience Research
- Vol. 86 (9), 2100-2110
- https://doi.org/10.1002/jnr.21653
Abstract
HIV‐1 patients who abuse opiate‐based drugs, including heroin and morphine, are at a higher risk of developing HIV dementia. The effects of opiates are mediated predominantly through opioid receptors, which are expressed on glial cells. As HIV‐1 infection in the CNS is restricted to glial cells, experiments were designed to measure the cell‐specific effects of HIV Tat and morphine exposure on opioid receptor expression in both astrocytes and microglia. Specifically, the cell‐type‐specific pattern of mu opioid receptor (MOR), delta opioid receptor (DOR), and kappa opioid receptor (KOR) localization (surface vs. intracellular) and expression of opioid receptor mRNA were determined after exposure to morphine in the presence and the absence of Tat in primary cultured microglia and astrocytes. Data show that morphine treatment caused significantly decreased cell surface expression of opioid receptors in microglia but not in astrocytes. However, morphine treatment in the presence of Tat significantly increased intracellular expression of opioid receptors and prevented morphine‐induced cell surface opioid receptor down‐regulation in microglia. These findings document that cell surface opioid receptor expression is divergently regulated by morphine in microglia compared with in astrocytes, and further suggest that HIV‐Tat could exacerbate opioid receptor signaling in microglia by increasing receptor expression and/or altering ligand‐induced trafficking of opioid receptors.Keywords
This publication has 86 references indexed in Scilit:
- Expression of the Mu Opioid Receptor in the Human Immunodeficiency Virus Type 1 Transgenic Rat ModelJournal of Virology, 2007
- Calprotectin in microglia from frontal cortex is up‐regulated in schizophrenia: evidence for an inflammatory process?European Journal of Neuroscience, 2006
- An in Vitro Model of Morphine Withdrawal Manifests the Enhancing Effect on Human Immunodeficiency Virus Infection of Human T Lymphocytes through the Induction of Substance PThe American Journal of Pathology, 2006
- Separation of μ-Opioid Receptor Desensitization and Internalization: Endogenous Receptors in Primary Neuronal CulturesJournal of Neuroscience, 2006
- Does drug abuse alter microglial phenotype and cell turnover in the context of advancing HIV infection?Neuropathology and Applied Neurobiology, 2005
- Role of HIV-1 Tat and CC Chemokine MIP-1α in the pathogenesis of HIV associated central nervous system disordersJournal of NeuroVirology, 1999
- Exogenous tat protein activates central nervous system-derived endothelial cellsJournal of Neuroimmunology, 1994
- Morphine treatment in vitro or in vivo decreases phagocytic functions of murine macrophagesLife Sciences, 1993
- Neuronal loss in the hippocampus in Huntington's disease: a comparison with HIV infection.Journal of Neurology, Neurosurgery & Psychiatry, 1993
- Alteration of intracellular traffic by monensin; mechanism, specificity and relationship to toxicityBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1990